- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Michael Griffin Describes Daughters of Charity's Long History of Leadership
In the 180-plus years Daughters of Charity has been in New Orleans, the health system has implemented a number of innovative ideas, from air-conditioned hospitals to community health networks, according to Michael Griffin, president and CEO. The future is looking even brighter as more patients become insured and gain access to care, he added.
In the 180-plus years Daughters of Charity has been in New Orleans, the health system has implemented a number of innovative ideas, from air-conditioned hospitals to community health networks, according to Michael Griffin, president and CEO. The future is looking even brighter as more patients become insured and gain access to care, he added.
Transcript (slightly modified)
How has Daughters of Charity been a leader throughout its long history?
Daughters of Charity has been in the New Orleans market for 180 years, over 180 years, and I like to say that Daughters of Charity probably has always been a little ahead of their time, so developing hospitals back in the 1800s. Actually, Daughters of Charity, believe it or not, the hospital they had in New Orleans was the first hospital with centralized air conditioning units in healthcare. It’s a little known fact.
But then we got out of the hospital business and really started focusing on communities and taking care of patients in communities and where they live. We, since Katrina, have developed this very large network taking care of about 50,000 individuals in their neighborhood, in their communities, and then working with those communities, community leadership, the churches, the schools, a lot of the community centers, there’s senior centers there, working with business leadership in those neighborhoods, really to better coordinate services, care, and other.
I think the future of Daughters of Charity is looking great in New Orleans. We want to be a model not only for Ascension Health, which we are part of that national health system, but a model for the country in care coordination and taking care of populations without regard for whatever insurance or payer they have. Because at one point when I got there in 2008, we were 72% uninsured. We’ve worked very hard with staff to get people on insurance and the exchanges and the Medicaid expansion, and so now we are 10% uninsured. Coverage, to us, equals better access and we strive all the time to help people get coverage that are uninsured.
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Key Indicators of Myasthenia Gravis Disease Progression Reduced With Efgartigimod
April 18th 2025Research presented at the recent annual meeting of the Academy of Managed Care Pharmacy highlights outcomes among patients who have anti-acetylcholine receptor antibody-positive myasthenia gravis that include reduced exacerbations and need for immunoglobulin.
Read More
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
Bias Reduction, Better Access Key to COVID-19 Equity Gains
April 14th 2025Interventions that target enhancing health care equity among communities disproportionately affected by the COVID-19 pandemic can be improved by including comprehensive needs assessments at the patient, provider, and health system levels.
Read More
Orca-T showed lower rates of graft-vs-host disease or infection compared with allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome (MDS) or acute leukemias in the Precision-T trial, Caspian Oliai, MD, MS, UCLA Bone Marrow Transplantation Stem Cell Processing Center, said.
Read More
